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Tyrosine phosphorylation of focal adhesion kinase (FAK) creates a high-affinity binding site for
the src homology 2 domain of the Src family of tyrosine kinases. Assembly of a complex between
FAK and Src kinases may serve to regulate the subcellular localization and the enzymatic activity
of members of the Src family of kinases. We show that simultaneous overexpression of FAK and
pp60c-src or p59fyn results in the enhancement of the tyrosine phosphorylation of a limited number
of cellular substrates, including paxillin. Under these conditions, tyrosine phosphorylation of
paxillin is largely cell adhesion dependent. FAK mutants defective for Src binding or focal
adhesion targeting fail to cooperate with pp60c-src or p59fyn to induce paxillin phosphorylation,
whereas catalytically defective FAK mutants can direct paxillin phosphorylation. The negative
regulatory site of pp60c-src is hypophosphorylated when in complex with FAK, and coexpression
with FAK leads to a redistribution of pp60c-src from a diffuse cellular location to focal adhesions.
A FAK mutant defective for Src binding does not effectively induce the translocation of pp60c-src
to focal adhesions. These results suggest that association with FAK can alter the localization of Src
kinases and that FAK functions to direct phosphorylation of cellular substrates by recruitment of
Src kinases.
INTRODUCTION
The focal adhesion kinase (FAK) is a protein tyrosine
kinase (PTK) that is regulated by multiple extracellular
stimuli (Schaller and Parsons, 1994; Schwartz et al., 1995).
Cell adhesion to proteins of the extracellular matrix, e.g.,
fibronectin or collagen, via their receptors, the integrins
(Hynes, 1992), induces the tyrosine phosphorylation of
FAK and stimulation of its enzymatic activity (Burridge et
al., 1992; Guan and Shalloway, 1992; Hanks et al., 1992;
Kornberg et al., 1992; Lipfert et al., 1992). Treatment of
cells with a number of agents including growth factors,
neuropeptides, and lysophosphatidic acid can induce the
phosphorylation of FAK on tyrosine (Zachary et al., 1992;
Kumagai et al., 1993; Sinnett-Smith et al., 1993; Barry and
Critchley, 1994; Chrzanowska-Wodnicka and Burridge,
1994; Matsumoto et al., 1994; Polte et al., 1994; Rankin and
Rozengurt, 1994; Ridley and Hall, 1994; Seufferlein and
Rozengurt, 1994). Thus multiple stimuli, acting on distinct
cell surface receptors that trigger discrete cytoplasmic
signaling pathways, converge to induce a common re-
sponse, the tyrosine phosphorylation of FAK.
Like other PTKs, tyrosine phosphorylation of FAK plays
an important role in regulating signaling. Six tyrosine resi-
dues within FAK have been identified as sites of phosphor-
ylation. The major site of autophosphorylation is tyrosine
397 (Chan et al., 1994; Schaller et al., 1994; Calalb et al., 1995;
Eide et al., 1995), whereas tyrosine residues 407, 576, 577,
861, and 925 are sites that become phosphorylated by Src
(Schlaepfer et al., 1994; Calalb et al., 1995, 1996; Schlaepfer
and Hunter, 1996). Phosphorylation at 576 and 577 might be
modifications that regulate enzymatic activity (Calalb et al.,
1995), whereas phosphorylation of tyrosine 925 regulates
protein–protein interactions by creating a binding site for
the src homology 2 (SH2) domain of the Grb2 adaptor pro-
tein (Schlaepfer et al., 1994; Schlaepfer and Hunter, 1996).
Tyrosine 397 is embedded within a sequence that is virtually
identical to the consensus binding site for the Src SH2
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domain (Songyang et al., 1993). Indeed, FAK associates with
pp60src via an SH2-mediated interaction in src-transformed
chicken embryo cells, and mutation of tyrosine 397 impairs
the ability of FAK to complex with Src (Cobb et al., 1994;
Schaller et al., 1994; Xing et al., 1994; Eide et al., 1995). In
addition, FAK contains a binding site for the Src homology
3 (SH3) domain of Src that may contribute to stabilization of
the FAK/Src complex (Thomas et al., 1998).
FAK has been implicated in a number of biological pro-
cesses, including controlling the rate of cell spreading and
cell migration and generating an antiapoptotic signal in
response to cell adhesion (Ilic et al., 1995; Cary et al., 1996;
Frisch et al., 1996; Gilmore and Romer, 1996; Hungerford et
al., 1996; Richardson and Parsons, 1996). Expression of the
C-terminal noncatalytic domain of FAK, called FRNK, in
chicken embryo (CE) cells impairs FAK signaling and re-
duces the rate of spreading on fibronectin (Richardson and
Parsons, 1996). Coexpression of exogenous wild-type FAK,
but not FAK397F, rescues the cell-spreading defect (Richard-
son et al., 1997). Overexpression of FAK in Chinese hamster
ovary cells leads to enhanced cell motility, whereas overex-
pression of a FAK mutant with a phenylalanine for tyrosine
substitution at residue 397 does not (Cary et al., 1996). Mad-
in–Darby canine kidney (MDCK) cells undergo a form of
apoptosis called anoikis when they are cultured in the ab-
sence of adhesion to an extracellular matrix. Expression of a
membrane-bound, CD2-FAK chimeric molecule in MDCK
cells blocks anoikis (Frisch et al., 1996); however, a CD2-
FAK397F mutant cannot block anoikis in MDCK cells held in
suspension (Frisch et al., 1996). Each of these results suggests
that complex formation with Src family PTKs may be re-
quired for FAK function.
pp60c-src is a tightly regulated PTK, and its activity is
repressed by sequences at its C terminus. Phosphorylation
of a tyrosine residue within this region, tyrosine 527, by the
C-terminal Src kinase (Csk) PTK is required for repression
of the activity of pp60c-src (Kmiecik and Shalloway, 1987;
Piwnica-Worms et al., 1987; Nada et al., 1991). Solution of the
crystal structure of Src and Hck in their inactive conforma-
tion has verified that the mechanism of repression involves
an intramolecular interaction between the tyrosine phos-
phorylated C-terminal sequences and the SH2 domain
(Sicheri et al., 1997; Xu et al., 1997). In the inactive conforma-
tion, the SH3 domain is also involved in an intramolecular
interaction. Dephosphorylation of the negative regulatory
site is one mechanism by which the Src family PTKs might
be activated in response to extracellular stimuli. An alterna-
tive mechanism might be the displacement of the negative
regulatory element from the SH2 domain and/or disruption
of the intramolecular SH3-mediated interaction by presen-
tation of higher-affinity SH2 or SH3 domain-binding ligands
(Liu et al., 1993; Alonso et al., 1995; Alexandropoulos and
Baltimore, 1996; Moarefi et al., 1997; Thomas et al., 1998).
In growing cells, pp60c-src is diffusely distributed in the
cell with prominent perinuclear staining and colocalizes
with endosomal membrane markers (Reynolds et al., 1989;
Kaplan et al., 1992). Activation of Src leads to a profound
change in its cellular location. pp60v-src and an oncogenic
variant of pp60c-src with a mutation of tyrosine 527 to phe-
nylalanine are found in podosomes (Rohrschneider, 1980;
Kaplan et al., 1994), structures unique to transformed cells
that contain some of the components of focal adhesions. In
csk2/2 fibroblasts, exogenously expressed pp60c-src, which is
hypophosphorylated at its C terminus, targets to focal ad-
hesions (Howell and Cooper, 1994). In src2/2 fibroblasts,
exogenously expressed pp60c-src exhibits a perinuclear stain-
ing in growing cells, but becomes localized to focal adhe-
sions when cells are plated onto fibronectin (Kaplan et al.,
1995). Cell adhesion to fibronectin also stimulates assembly
of a complex between FAK and pp60c-src and a transient
activation of pp60c-src (Schlaepfer et al., 1994; Kaplan et al.,
1995). Together these observations suggest that complex
formation with FAK may regulate the subcellular localiza-
tion and enzymatic activity of pp60c-src.
We set out to test the feasibility of these hypotheses by
examining the subcellular localization and activity of pp60c-src
(or p59fyn) in vivo when expressed alone, or coexpressed with
FAK, in CE cells. We found that coexpression of FAK with
pp60c-src or p59fyn results in increased tyrosine phosphoryla-
tion of a limited set of cellular proteins, including paxillin, that
pp60c-src is hypophosphorylated at its negative regulatory ele-
ment when it is physically associated with FAK, and that
coexpression with FAK leads to a dramatic relocalization of
pp60c-src to cellular focal adhesions.
MATERIALS AND METHODS
Cells and Viruses
CE cells were prepared as described (Reynolds et al., 1989). The FAK
and src and fyn cDNAs were expressed using replication-competent
retroviral vectors that were introduced into CE cells by transfection
as described (Reynolds et al., 1989). One week to 10 d after trans-
fection, the cultures were expressing maximal amounts of the pro-
tein of interest. At this time viral stocks were made from subcon-
fluent cultures. Culture medium was changed, and the cells were
incubated for 20–24 h. The culture medium was collected, cells and
cell debris were pelleted in a clinical centrifuge, and the virus-
containing supernatant was aliquoted and stored at 270°C. Coex-
pression of FAK and pp60src was achieved by transfection of one
retroviral construct into the cells followed by superinfection with a
viral stock of the other construct 1 wk later. In some experiments,
coinfection was achieved by mixing cells infected with one vector
with cells expressing the other retroviral vector. The cells were
analyzed 5–7 d later. For experiments designed to test cell adhesion-
dependent signaling, cells were trypsinized, and the trypsin was
neutralized by washing twice in PBS containing 0.5 mg/ml soybean
trypsin inhibitor. Cells were resuspended in serum-free medium
and adhered to plastic dishes coated with fibronectin (5 mg/cm2).
After incubation at 37°C the cells were lysed.
Constructs
Construction of RCAS A retroviral vectors (Hughes et al., 1987)
containing the FAK cDNA insert or the FAK mutants dl853–963 and
dl965–1012 have been described (Hildebrand et al., 1993; Schaller et
al., 1993a). An RCAS B retroviral vector containing the FAK cDNA
was engineered using a similar strategy (a gift of Dr. Alan Richard-
son, University of Virginia). src was expressed using the A-type
vector pRLc-src (Reynolds et al., 1989) or an RCAS B retroviral
vector. The c-src and fyn cDNAs were subcloned into the multiple
cloning site of cla12Nco (Hughes et al., 1987); the inserts were
excised using the flanking ClaI sites and then inserted into the ClaI
site of RCAS B. The use of these different vectors allowed the
coexpression of two cDNAs in CE cells, one introduced using an A
type virus and the other introduced using a compatible B type
retrovirus. The Altered Sites mutagenesis system (Promega, Madi-
son WI) was used to create substitutions of phenylalanine for ty-
rosine residues 576 and 577 within FAK by oligonucleotide-directed
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mutagenesis. A catalytically inactive variant of FAK, FAKK454R,
has been described (Hildebrand et al., 1993). A double mutant,
FAK397F/K454R, was also created by ligating a fragment of FAK
containing the Y397F point mutation (nucleotide 1 to 1381) to a
fragment of FAK containing the K454R mutation (nucleotides 1382
to 3248) using the Bsp EI site at nucleotide 1381. This construct was
then rescued into RCAS A. Two variants of pp60c-src were used to
assess the importance of its enzymatic activity in synergizing with
FAK. SrcDPK has the catalytic domain deleted but retains the
unique, SH3, SH2, and C-terminal regulatory domains. This was
constructed by PCR amplification of the sequences encoding the
C-terminal regulatory domain (nucleotides 1651 through 1742),
which were ligated in frame to nucleotides 1 through 884 of the src
cDNA using the Mlu I site that lies between the coding sequences
for the SH2 and catalytic domains. This strategy resulted in the
deletion of codons 260 through 513 inclusive and insertion of a
histidine residue at this site. SrcA430V contains a valine substitution
for alanine at residue 430, a residue that is highly conserved in
protein kinases, and exhibits ,10% of the activity of wild-type
pp60c-src (Wilson et al., 1989). Sequences encoding the C-terminal
half of the mutant pp60c-src were amplified by PCR from the paren-
tal vector (pMsrc; a gift of Dr. Sally Parsons, University of Virginia)
and ligated to the sequences encoding the NH2-terminal half of
pp60c-src using the Mlu I site at nucleotide 884, then subcloned into
the RCAS B vector. All sequences amplified by PCR were subjected
to nucleotide sequencing to verify that no mutations were intro-
duced during the procedure.
Protein Analysis
Cells were lysed in modified radioimmunoprecipitation assay buffer
as described (Kanner et al., 1989), and protein concentrations were
determined using the bicinchoninic acid protein assay (Pierce, Rock-
ford, IL). Proteins were analyzed using mAb 2A7 (Kanner et al.,
1990) or polyclonal antiserum BC3 (Schaller et al., 1992) for FAK,
mAb EC10 for pp60src (Parsons et al., 1984), polyclonal antiserum
428 for p59fyn (a generous gift of Dr. Andre Veillette, McGill Uni-
versity) (Davidson et al., 1992), polyclonal antiserum 605 for paxillin
(Thomas and Schaller, unpublished observations), and commer-
cially available mAbs for paxillin and p59fyn (Transduction Labora-
tories, Lexington, KY). Proteins were immunoprecipitated from 0.5
to 1 mg of cellular protein, and immune complexes were collected
using protein A Sepharose (Pharmacia, Piscataway, NJ) or goat
anti-mouse antibodies conjugated to agarose (Sigma, St. Louis, MO).
Immune complexes were washed twice with modified radioimmu-
noprecipitation assay, twice with Tris-buffered saline (10 mM Tris-
HCl, pH 8.0, 150 mM NaCl), then denatured by boiling in Laemmli
sample buffer (Laemmli, 1970). The samples were analyzed by SDS-
PAGE on an 8% gel (Laemmli, 1970), transferred to nitrocellulose,
and analyzed by Western blotting (immunoblotting) using the an-
tibodies described above (Kanner et al., 1990). Phosphotyrosine was
detected by blotting with the recombinant antiphosphotyrosine
mAb RC20 (Transduction Laboratories). Primary antibodies were
detected using horseradish peroxidase-conjugated secondary anti-
bodies, enhanced chemiluminescence (Amersham, Arlington
Heights, IL), and exposure to x-ray film. For semiquantitative
comparison of phosphotyrosine levels, films were scanned and
analyzed using Scion Image for Windows (Scion Corporation,
Frederick, MD).
Phosphorylation Analysis
Cells were incubated with 2 mCi/ml 32Pi (8500–9120 Ci/mmol;
Dupont/NEN, Wilmington, DE) in DMEM containing 10% fetal calf
serum and 10% conditioned medium for 8–10 h at 37°C. The cells
were lysed as above, precleared with goat anti-mouse agarose, and
then FAK was immunoprecipitated with mAb 2A7 and pp60src was
immunoprecipitated with mAb EC10. After SDS-PAGE and transfer
to nitrocellulose, FAK and pp60src were visualized by autoradiog-
raphy. The pp60src bands, directly immunoprecipitated by EC10 or
coimmunoprecipitated with FAK, were excised and cleaved with
cyanogen bromide (CNBr) (Sigma) as described (Luo et al., 1991).
After washing, the fragments were resolved using a tricine gel
electrophoresis system (Schagger and von Jagow, 1987) and visual-
ized by autoradiography.
Immunofluorescence
Before immunofluorescence, subconfluent cultures were tryp-
sinized, then plated in DMEM 1 4% calf serum 1 1% chick serum
onto coverslips coated with fibronectin (5 mg/cm2). After incubation
for 1–2 h at 37°C, the cells were fixed with paraformaldehyde,
permeabilized with Triton X-100, and incubated with antibodies as
described (Reynolds et al., 1989; Wu et al., 1991). mAb EC10 was
used to detect pp60src, and rhodamine-conjugated goat anti-mouse
secondary antibodies (Affinipure, min X; Jackson Immunoresearch
Laboratories, West Grove, PA) was used to visualize the primary
antibody. In some experiments the cells were costained with BC3
and fluorescein-conjugated donkey anti-rabbit secondary antibodies
(Affinipure, min X; Jackson Immunoresearch Laboratories). The
cells were examined using a Leitz 633 (1.4 N.A.) objective and Leitz
Orthoplan microscope and photographed with an Olympus camera
using Kodak TMAX ASA 400 film. Alternatively, images were col-
lected with a Hamamatsu CCD camera and MetaMorph imaging
software (Universal Imaging, West Chester, PA). Control and ex-
perimental images were taken using identical exposures.
RESULTS
Coexpression of FAK and pp60c-src or p59fyn
Enhances Cellular Phosphotyrosine
To investigate the consequences of coexpression of FAK and
Src-family PTKs on cellular signaling, the phosphotyrosine
content of cellular proteins was examined by Western blot-
ting. FAK and pp60c-src or p59fyn were coexpressed in CE
cells using compatible, replication-competent retroviral ex-
pression vectors. Initial experiments using whole-cell lysates
from subconfluent cells demonstrated an elevation in the
phosphorylation of cellular proteins on tyrosine. As de-
scribed previously (Schaller and Parsons, 1995), overexpres-
sion of FAK resulted in little change in the profile of ty-
rosine-phosphorylated cellular proteins, with the exception
of the exogenously expressed FAK, which was tyrosine-
phosphorylated (Figure 1, A and B). Overexpression of
pp60c-src alone induced an increase in the phosphotyrosine
content of several cellular proteins, including 200-, 130-,
70–75-, and 60-kDa proteins. Despite the higher level of
phosphorylation of this discrete set of cellular proteins, these
cells were morphologically normal. Coexpression of FAK
and pp60c-src did lead to enhanced tyrosine phosphorylation
of a number of cellular proteins, most notably proteins of
125–130 kDa and 70–80 kDa (Figure 1A). Expression levels
of FAK and pp60c-src in these cells were examined by West-
ern blotting (Figure 1A, bottom panels). Equivalent levels of
the PTKs were observed when expressed alone or when
coexpressed with the other PTK.
Because p59fyn also complexes with FAK (Cobb et al.,
1994), p59fyn was tested for its ability to synergize with FAK
when expressed in CE cells. The fyn cDNA was subcloned
into the RCAS vector, expressed in CE cells, and the profile
of tyrosine phosphorylated cellular proteins was examined
by Western blotting. Overexpression of p59fyn induced very
little change in the pattern of phosphotyrosine-containing
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proteins in CE cells (Figure 1B); however, coexpression with
FAK led to an increase in the phosphotyrosine content of
200-, 125–130-, and 70–80-kDa proteins (Figure 1B). Western
blotting was performed to examine the expression of exog-
enous FAK and p59fyn and verify equal expression levels
between samples (Figure 1B, bottom panels).
Because pp60c-src can localize to cellular focal adhesions
(Howell and Cooper, 1994; Kaplan et al., 1994, 1995) and pp60v-
src induces tyrosine phosphorylation of focal adhesion-associ-
ated proteins in v-src–transformed cells (Schaller et al., 1993b),
it seemed likely that the major substrates for tyrosine phos-
phorylation might reside within focal adhesions. FAK was
identified as a component of the 125-kDa tyrosine-phosphory-
lated band by immunoprecipitation and Western blotting. Ex-
pression of pp60c-src or p59fyn induced a small increase in the
phosphotyrosine content of endogenous FAK (Figure 2, A and
B, top panels). Coexpression of either pp60c-src or p59fyn with
FAK resulted in enhanced tyrosine phosphorylation of the
exogenously expressed FAK, although the increment was more
pronounced upon coexpression with pp60c-src (Figure 2, A and
B, top panels). The control FAK Western blots demonstrate that
changes in phosphotyrosine were not the result of changes in
protein level.
The 70-kDa tyrosine-phosphorylated protein was identi-
fied as paxillin by immunoprecipitation with a paxillin mAb
and Western blotting with antiphosphotyrosine (Figure 2, A
and B, bottom panels). Expression of p59fyn or FAK induced
a small increase in the phosphotyrosine content of paxillin
(Figure 2B, bottom). Coexpression of p59fyn and FAK re-
sulted in a further increase in paxillin’s phosphotyrosine
content (Figure 2B, bottom). The migration of tyrosine-phos-
phorylated paxillin was heterogeneous, with some species
exhibiting retarded electrophoretic mobility relative to ba-
sally phosphorylated paxillin (Figure 2B, bottom, lane 4).
Expression of pp60c-src alone induced a dramatic increase in
the phosphotyrosine content of paxillin (Figure 2A, bottom,
lane 2). Despite the effect of pp60c-src expression alone on the
phosphorylation of paxillin, coexpression with FAK resulted
in a further increase in its tyrosine phosphorylation (Figure
2A, bottom, lane 4). Again, tyrosine-phosphorylated paxillin
exhibited a heterogeneous, retarded mobility. The immune
complexes were also probed with antipaxillin antibodies to
confirm that changes seen in the phosphotyrosine immuno-
blot were due to changes in phosphorylation and not to
differences in the amount of protein immunoprecipitated. In
samples exhibiting the highest level of tyrosine phosphory-
lation, a corresponding retardation in the mobility of paxil-
lin could be detected in the paxillin Western blots (Figure
2A, bottom, lane 4).
Changes in the level of paxillin phosphorylation was
semiquantitatively analyzed using Scion Image for Win-
dows software. Expression of FAK in CE cells resulted in a
1.9-fold increase in tyrosine phosphorylation (average of
eight experiments). Expression of fyn alone resulted in a
2.9-fold elevation of paxillin phosphorylation, whereas co-
expression of FAK and fyn led to an 8.7-fold increase in the
phosphotyrosine content of paxillin (average of eight exper-
iments). Src expression alone induced a ninefold increase in
paxillin phosphorylation, whereas coexpression of FAK and
Src resulted in a 12.8-fold increase in paxillin phosphoryla-
tion (average of four experiments).
Enhanced Paxillin Phosphorylation Requires Cell
Adhesion
Coexpression of FAK with pp60c-src or p59fyn resulted in
elevated tyrosine phosphorylation of paxillin in CE cells
growing in culture. To determine whether paxillin phos-
phorylation was regulated or constitutive in these cells, its
phosphotyrosine content was examined in cells in culture, in
cells held in suspension, and in cells plated onto fibronectin.
Cells expressing FAK and/or Src kinases were trypsinized;
the trypsin was neutralized with soybean trypsin inhibitor,
and the cells were resuspended in serum-free medium. The
cells were incubated in suspension or plated onto fibronec-
tin-coated plastic dishes and incubated at 37°C for 90 min.
Paxillin was immunoprecipitated, and the immune com-
Figure 1. FAK and Src-like PTKs synergize in vivo. (A) Twenty-
five micrograms of whole-cell lysate from CE cells (lane 1) or CE
cells expressing RCAS B FAK (lane 2), pRL c-src (lane 3), or RCAS
B FAK 1 pRL c-src (lane 4) were analyzed by Western blotting using
phosphotyrosine antibodies (top panel), mAb 2A7 to detect FAK
(middle panel), or mAb EC10 to detect pp60c-src (bottom panel). (B)
Twenty-five micrograms of whole-cell lysate from CE cells (lane 1)
or CE cells expressing RCAS B fyn (lane 2), RCAS A FAK (lane 3),
or RCAS A FAK 1 RCAS B fyn (lane 4) were analyzed by Western
blotting using phosphotyrosine antibodies (top panel), mAb 2A7 to
detect FAK (middle panel), or a fyn mAb (bottom panel).
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plexes were Western-blotted for phosphotyrosine or paxil-
lin. In CE cells, paxillin was tyrosine-phosphorylated in
subconfluent cells growing in culture (Figure 3, A and B,
lanes 1). Phosphotyrosine disappeared when the cells were
taken into suspension, and paxillin became tyrosine-phos-
phorylated upon cell adhesion to fibronectin (Figure 3, A
and B, lanes 2 and 3). Cells expressing FAK, fyn alone, or
FAK and fyn together exhibited complete dephosphoryla-
tion of paxillin when cells were taken into suspension (Fig-
ure 3, A and B). Paxillin became tyrosine-phosphorylated
upon adhesion to fibronectin, and adhesion-dependent
phosphorylation was enhanced in cells coexpressing FAK
and fyn (Figure 3B). In cells expressing pp60c-src or FAK and
pp60c-src, tyrosine phosphorylation of paxillin was elevated.
When the cells were held in suspension the phosphotyrosine
content of paxillin was reduced, demonstrating that
enhanced tyrosine phosphorylation was at least partially
adhesion dependent; however, there was significant ty-
rosine phosphorylation of paxillin in Src- and Src/FAK-
expressing cells held in suspension. Expression of Src in
src2/2 fibroblasts has been reported to induce paxillin phos-
phorylation that is only partially cell adhesion dependent
(Klinghoffer et al., 1999). Despite the elevated phosphoty-
rosine levels of paxillin in suspension, its phosphotyrosine
content was further increased upon cell adhesion to fi-
bronectin. Thus tyrosine phosphorylation of paxillin in CE
cells coexpressing FAK and Src is at least partially depen-
dent on cell adhesion.
Enzymatic Activity of pp60c-src Is Required for
Substrate Phosphorylation
To elucidate how FAK and the Src-like PTKs cooperate to
enhance tyrosine phosphorylation in vivo, mutants were
analyzed. Two different pp60c-src mutants were examined to
determine the importance of catalytic activity in synergy
with FAK. One mutant, SrcDPK, has a deletion from residues
260 to 513 inclusive, and the second, SrcA430V, has a single
substitution of a valine for alanine at residue 430. This
residue is within the highly conserved APE motif within
subdomain VIII of the catalytic domain (Hanks et al., 1988),
and the valine mutation renders the protein catalytically
defective (Wilson et al., 1989).
The phosphotyrosine content of proteins from cells ex-
pressing these constructs was analyzed by Western blotting.
Interestingly, expression of SrcDPK in CE cells induced the
tyrosine phosphorylation of a 140,000-kDa protein (Figure
4A, lane 3). This is presumably p130cas because expression of
a similar Src construct in src2/2 fibroblasts was sufficient to
induce its tyrosine phosphorylation (Schlaepfer et al., 1997).
Coexpression of SrcDPK and FAK did not lead to an increase
in tyrosine phosphorylation of this or any other cellular
protein (Figure 4A). Expression of FAK and SrcDPK was
verified by Western blotting; however, the level of exog-
enously expressed SrcDPK was always less than the level of
exogenously expressed pp60c-src. Expression of SrcA430V did
not alter the tyrosine phosphorylation of cellular proteins
Figure 2. FAK and paxillin are substrates for
phosphorylation. The phosphotyrosine content
of FAK (top panels) and paxillin (bottom panels)
from CE cells coexpressing FAK and c-src (A) or
FAK and fyn (B) was examined by immunopre-
cipitation and Western blotting. (A) FAK (top)
and paxillin (bottom) were immunoprecipitated
from lysates of CE cells (lane 1) or CE cells ex-
pressing RCAS B c-src (lane 2), RCAS A FAK
(lane 3), or RCAS A FAK 1 RCAS B c-src (lane 4).
Immune complexes were analyzed by Western
blotting using a phosphotyrosine antibody, an
anti-FAK rabbit serum, or a paxillin mAb. (B)
FAK and paxillin were immunoprecipitated from
lysates of CE cells (lane 1) or CE cells expressing
RCAS B fyn (lane 2), RCAS A FAK (lane 3), or
RCAS B fyn 1 RCAS A FAK (lane 4) and ana-
lyzed as in A.
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(Figure 4B, lane 3), and coexpression with wild-type FAK
failed to enhance tyrosine phosphorylation (Figure 4B, lane
4). The enhanced tyrosine phosphorylation of proteins in
response to coexpression of FAK and pp60c-src is shown for
comparison (Figure 4B, lane 5). Western blotting demon-
strated expression of FAK, pp60c-src, and SrcA430V. These
results indicate that the enzymatic activity of pp60c-src is
required for synergy with FAK in vivo.
Tyrosine Phosphorylation of FAK Mutants in Vivo
Mutants of FAK were coexpressed with pp60c-src and p59fyn
to determine some of the features of FAK required to induce
downstream signaling. The mutants analyzed included
FAK397F, FAK576F/577F, a variant with phenylalanine substi-
tuted for two regulatory sites of tyrosine phosphorylation
that are substrates for pp60src, and FAK454R, which is cata-
lytically defective. Initial experiments examined tyrosine
phosphorylation of the FAK variants themselves upon co-
expression with Src family PTKs. Expression of pp60c-src
alone induced a small increase in the phosphotyrosine con-
tent of endogenous FAK (Figure 5A, lane 2), whereas ex-
pression of p59fyn did not (Figure 5B, lane 2). As previously
described, FAK397F contains little if any phosphotyrosine
(Figure 5, A and B, lanes 5). Coexpression with p59fyn did
not enhance phosphorylation of FAK397F (Figure 5B, lane 6).
In some experiments, coexpression with pp60c-src induced a
small increase in the tyrosine phosphorylation of FAK397F
(Figure 5A, lane 6), and in others it did not. The phospho-
tyrosine content of FAK576F/577F was increased in cells co-
expressing pp60c-src and p59fyn (Figure 5A, lanes 7 and 8; our
unpublished results). Despite its catalytic inactivity,
FAK454R was tyrosine-phosphorylated when expressed in
CE cells, albeit at reduced levels relative to wild-type FAK
(Figure 5B, lane 7). Coexpression with pp60c-src or p59fyn led
to increased tyrosine phosphorylation (Figure 5, A and B, lanes
10 and 8, respectively). A double mutant, FAK454R/397F, with
point mutations destroying both catalytic activity and the au-
tophosphorylation site, contained no phosphotyrosine when
expressed alone; when coexpressed with pp60c-src or p59fyn, it
did not exhibit enhanced tyrosine phosphorylation (Figure 5A,
lanes 11 and 12; 5B, lanes 9 and 10). The low level of phospho-
tyrosine detected upon coexpression of pp60c-src and p59fyn
with FAK454R/397F is likely due to the presence of wild-type
endogenous FAK in the immune complex. Control FAK West-
ern blots demonstrate that differences in phosphotyrosine con-
tent in the presence and absence of Src family PTKs is not due
to differences in FAK expression level (Figure 5, A and B).
pp60src (Figure 5C) and p59fyn Western blots (Figure 5D) ver-
ified coexpression of these PTKs with each of the FAK variants.
These results indicate that mutants of FAK, even one lacking
catalytic activity, can serve as direct or indirect substrates for
pp60c-src or p59fyn providing that the autophosphorylation/Src
SH2 binding site of FAK is intact.
Association of FAK Mutants with pp60c-src
and p59fyn
Given that the integrity of the Src SH2 binding site was
required for enhanced tyrosine phosphorylation of FAK,
each FAK variant was tested for its association with pp60c-src
and p59fyn in vivo by coimmunoprecipitation. pp60c-src or
Figure 3. Cell adhesion-dependent
tyrosine phosphorylation of paxillin.
(A) CE cells (lanes 1–3) or CE cells
expressing RCAS A FAK (lanes 4–6),
RCAS B Src (lanes 7–9), or RCAS B Src
and RCAS A FAK (lanes 10–12) were
analyzed. Paxillin was immunopre-
cipitated from lysates of cells in culture
(lanes 1, 4, 7, and 10), cells held in
suspension (lanes 2, 5, 8, and 11), or
cells plated onto fibronectin (lanes 3, 6,
9, and 12). The immune complexes
were blotted for phosphotyrosine (top
panel) or paxillin (bottom panel). Ex-
pression of FAK and Src was verified
by Western blotting (C). (B) CE cells
(lanes 1–3) or CE cells expressing
RCAS A FAK (lanes 4–6), RCAS B fyn
(lanes 7–9), or RCAS B fyn and RCAS
A FAK (lanes 10–12) were analyzed.
Paxillin was immunoprecipitated from
lysates of cells in culture (lanes 1, 4, 7,
and 10), cells held in suspension (lanes
2, 5, 8, and 11), or cells plated onto
fibronectin (lanes 3, 6, 9, and 12). The
immune complexes were blotted for
phosphotyrosine (top panel) or paxillin
(bottom panel). Expression of FAK and
fyn was verified by Western blotting (D).
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p59fyn were immunoprecipitated from lysates, and the pres-
ence of FAK in the immune complexes was detected by
Western blotting. Endogenous FAK could be coimmunopre-
cipitated with exogenously expressed pp60c-src and p59fyn
(Figure 6, A and B, lanes 2 and 1, respectively). Coexpression
of wild-type FAK resulted in a large increase in the amount
of FAK recovered in pp60c-src and p59fyn immune com-
plexes, indicating that the exogenous proteins could also
associate (Figure 6, A and B, lanes 3 and 2, respectively).
FAK576F/577F and FAK454R could also be coimmunoprecipi-
tated with pp60c-src and p59fyn (Figure 6, A and B; our unpub-
lished results), although the amount of these variants in com-
plex with Src family PTKs was reduced relative to wild-type
FAK. As anticipated, both FAK397F and FAK454R/397F failed to
associate with pp60c-src and p59fyn (Figure 6, A and B). Thus
the catalytic activity of FAK is not essential for association with
Src family PTKs.
Catalytic Activity of Exogenous FAK Is Not
Required for Paxillin Phosphorylation
The FAK variants were next examined for their ability to
induce tyrosine phosphorylation of a downstream substrate,
i.e., paxillin, when coexpressed with Src or fyn. FAK397F
failed to induce paxillin phosphorylation when coexpressed
with pp60c-src or p59fyn, demonstrating that the physical
association of the two PTKs was necessary for downstream
signaling (Figure 7, B and C, lanes 6 and 5, respectively).
FAK576F/577F induced tyrosine phosphorylation of paxillin
when coexpressed with pp60c-src or p59fyn, indicating that
phosphorylation of these regulatory sites is not essential for
signaling to paxillin (Figure 7, A and C, lanes 6). FAK454R
also induced tyrosine phosphorylation of paxillin when co-
expressed with p59fyn or pp60c-src (Figure 7, B and C, lanes
8 and 7, respectively). Therefore, the catalytic activity of the
mutant was not required to induce a downstream signal.
The mechanism by which catalytically defective FAK could
send a signal appeared to be via recruitment of the Src
family PTK because the double mutant (FAK397F/454R) was
defective for induction of paxillin phosphorylation (Figure
7B, lane 10; our unpublished results). Therefore, the critical
requirement for downstream signaling was apparently the
assembly of a complex between FAK and the Src family
PTKs rather than the enzymatic activity of FAK.
Focal Adhesion Localization of FAK Is Required to
Induce Paxillin Phosphorylation
To determine the role of focal adhesion targeting of FAK in
the induction of paxillin phosphorylation, two deletion mu-
tants defective for focal adhesion localization were analyzed
(Hildebrand et al., 1993). Expression of dl853-963 or dl965-
1012 in CE cells did not alter the level of tyrosine phosphor-
ylation of paxillin relative to the level observed in control
cells (Figure 8). Although coexpression of wild-type FAK
with Src or fyn led to a pronounced increase in tyrosine
phosphorylation of paxillin, coexpression of dl853-963 or dl
965-1012 with Src (Figure 8A) or fyn (Figure 8B) did not
induce an increase in the phosphotyrosine content of paxil-
lin. Therefore, targeting of FAK to focal adhesions is re-
quired for the direction of paxillin phosphorylation in com-
bination with Src family kinases.
pp60c-src in Complex with FAK Is
Hypophosphorylated at Tyrosine 527
One further prediction of the hypothesis is that Src would
exist in an altered, active conformation when in complex
with FAK. This hypothesis was tested by examining the
phosphorylation status of tyrosine 527, the negative regula-
tory phosphorylation site of pp60c-src that forms an intramo-
lecular interaction with the SH2 domain in the inactive
conformation. Cells were labeled with 32P-orthophosphate,
lysed, and pp60c-src-isolated either by coimmunoprecipita-
Figure 4. Catalytically inactive pp60c-src fails to synergize with
FAK. (A) Twenty-five micrograms of whole-cell lysate from CE cells
(lane 1) or CE cells expressing RCAS B FAK (lane 2), RCAS A
SrcDPK (lane 3), or RCAS B FAK 1 RCAS A SrcDPK (lane 4) were
analyzed by Western blotting using phosphotyrosine antibodies
(top panel), mAb 2A7 to detect FAK (middle panel), or mAb EC10
to detect SrcDPK (bottom panel). (B) Twenty-five micrograms of
whole-cell lysate from CE cells (lane 1) or CE cells expressing RCAS
A FAK (lane 2), RCAS B SrcA430V (lane 3), RCAS A FAK 1 RCAS B
SrcA430V (lane 4), or RCAS A FAK 1 RCAS B c-src (lane 5) were
analyzed by Western blotting using phosphotyrosine antibodies
(top panel), mAb 2A7 to detect FAK (middle panel), or mAb EC10
to detect pp60c-src (bottom panel).
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tion with FAK or direct immunoprecipitation using an anti-
pp60src mAb. The immune complexes were resolved by
SDS-PAGE and transferred to nitrocellulose (Figure 9A). The
membrane containing the radiolabeled pp60c-src band was
cut out and incubated with CNBr (Luo et al., 1991). The
resulting proteolytic fragments were separated on a 16%
tricine SDS-polyacrylamide gel and visualized by autora-
diography. CNBr cleavage of pp60c-src generates three major
phosphorylated fragments of 30, 8–9, and 4 kDa, the latter
containing tyrosine 527 (Schuh and Brugge, 1988; Clark and
Brugge, 1993). The CNBr cleavage products of the 60-kDa
band found in both the Src and FAK immunoprecipitations
contained phosphorylated fragments of 30 and 8–9 kDa
(Figure 9B). Presumably the 8- to 9-kDa fragment contains
tyrosine 416 because it exhibits an electrophoretic mobility
similar to the major phosphorylated CNBr fragment from
oncogenically active Src (our unpublished results). A similar
fragment was observed in Src immunoprecipitated from
cells expressing c-Src alone (our unpublished results). Al-
though this observation was surprising, it was consistent
with the finding that c-Src alone could induce tyrosine phos-
phorylation of cellular substrates like paxillin. In the pp60c-src
sample isolated by direct immunoprecipitation, a prominent
4-kDa CNBr fragment was detected (Figure 9B). This band was
absent from the pp60c-src population that was isolated by co-
immunoprecipitation with FAK (Figure 9B). The failure to
detect phosphorylation of the tyrosine 527-containing peptide
is consistent with an alteration in the conformation of pp60c-src
upon binding FAK.
Association with FAK Targets pp60c-src to Focal
Adhesions
To test whether the formation of the FAK/pp60c-src complex
may recruit pp60c-src into focal adhesions, the subcellular
localization of pp60c-src was determined by immunofluores-
cence. Endogenous pp60c-src could not be detected in normal
or FAK overexpressing CE cells by immunofluorescence
using either mAb EC10 or 327. The typical staining pattern
seen in CE cells was a very faint cellular staining similar to
background (Figure 10A). Therefore, the subcellular local-
ization of exogenously expressed pp60c-src was examined. In
cultures of growing cells, exogenously expressed pp60c-src
exhibited a diffuse staining pattern with a prominent perinu-
clear and membrane staining as previously described (Reyn-
olds et al., 1989; our unpublished results). Cells expressing
pp60c-src alone or pp60c-src and FAK together exhibited the
same pattern of Src staining in growing, subconfluent mono-
layer culture (our unpublished results).
Figure 5. Tyrosine phosphorylation of mutants of
FAK upon coexpression with src or fyn. In A and B,
FAK was immunoprecipitated from cell lysates and
Western-blotted for phosphotyrosine (top) and FAK
(bottom). (A) FAK was analyzed from CE cells (lane
1) or CE cells expressing RCAS B src (lane 2), RCAS
A FAK (lane 3), RCAS A FAK 1 RCAS B src (lane 4),
RCAS A FAK397F (lane 5), RCAS A FAK397F 1 RCAS
B src (lane 6), RCAS A FAK576/577FF (lane 7), RCAS A
FAK576/577FF 1 RCAS B src (lane 8), RCAS A
FAK454R (lane 9), RCAS A FAK454R 1 RCAS B src
(lane 10), RCAS A FAK454R/397F (lane 11), or RCAS
A FAK454R/397F 1 RCAS B src (lane 12). (B) FAK
was analyzed from CE cells (lane 1) or CE cells
expressing RCAS B fyn (lane 2), RCAS A FAK
(lane 3), RCAS A FAK 1 RCAS B fyn (lane 4),
RCAS A FAK397F (lane 5), RCAS A FAK397F 1
RCAS B fyn (lane 6), RCAS A FAK454R (lane 7),
RCAS A FAK454R 1 RCAS B fyn (lane 8), RCAS A
FAK454R/397F (lane 9), or RCAS A FAK454R/397F 1
RCAS B fyn (lane 10). (C) Twenty-five micrograms
of whole-cell lysate from CE cells (lane 1) or CE
cells expressing RCAS B src (lane 2), RCAS A FAK
1 RCAS B src (lane 3), RCAS A FAK397F 1 RCAS
B src (lane 4), RCAS A FAK576/577FF 1 RCAS B src
(lane 5), RCAS A FAK454R 1 RCAS B src (lane 6),
or RCAS A FAK454R/397F 1 RCAS B src (lane 7)
was Western-blotted with a src antibody. (D)
Twenty-five micrograms of whole-cell lysate from
CE cells (lane 1) or CE cells expressing RCAS B fyn
(lane 2), RCAS A FAK 1 RCAS B fyn (lane 3),
RCAS A FAK397F 1 RCAS B fyn (lane 4), RCAS
A FAK454R 1 RCAS B fyn (lane 5), or RCAS A
FAK454R/397F 1 RCAS B fyn (lane 6) was Western-
blotted with an fyn antibody.
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Because formation of the FAK/pp60c-src complex and lo-
calization of exogenous pp60c-src to focal adhesions report-
edly occurs after cell adhesion to fibronectin (Schlaepfer et
al., 1994; Kaplan et al., 1995), the subcellular distribution of
pp60c-src was reexamined 1–2 h after adhesion to fibronectin.
In cells overexpressing pp60c-src alone, a diffuse staining
with prominent perinuclear staining was again observed
(Figure 10C). This staining pattern was observed in every
cell, and no evidence of focal adhesion localization of Src in
these cells was ever seen. Coexpression of FAK with Src in
CE cells induced a profound change in the subcellular dis-
tribution of pp60c-src, which became predominantly local-
ized to structures resembling focal adhesions (Figure 10D).
The majority of Src-expressing cells in these cultures exhib-
ited pale cytoplasmic staining and prominent staining in
focal adhesions. To verify the colocalization of exogenous
pp60c-src with exogenously expressed FAK, cells were
costained with mAb EC10 to detect pp60c-src and with a
rabbit polyclonal antiserum, BC3, to detect FAK. Under the
staining conditions used, endogenous FAK was poorly de-
tected. Most CE cells (expressing no exogenous protein)
exhibited a pale staining with punctate cytoplasmic staining
and dim focal adhesions (Figure 10B). There was variability
in staining, and some cells contained easily detectable focal
adhesions (Figure 10B). Cells expressing exogenous FAK
exhibited a brighter cytoplasmic staining and very bright
focal adhesion staining (Figure 10E). In cells coexpressing
Src and FAK, the Src staining in focal adhesions was coin-
cident with the FAK focal adhesion staining pattern demon-
strating colocalization of both proteins to focal adhesions
(Figure 10F). To determine whether the relocalization of
pp60c-src was dependent on binding FAK, a mutant with a
phenylalanine for tyrosine substitution at residue 397,
FAK397F, was coexpressed with pp60c-src. This mutation re-
moves the major site of autophosphorylation of FAK, which
serves as a binding site for the SH2 domain of pp60c-src
(Chan et al., 1994; Schaller et al., 1994; Calalb et al., 1995; Eide
et al., 1995). FAK397 is discretely localized to focal adhesions
(Figure 11, A and C); however, coexpression of FAK397F with
pp60c-src did not induce the same dramatic change in the
cellular localization of pp60c-src that occurred upon coex-
pression with wild-type FAK (Figure 11, B and D). In these
cells, pp60c-src predominantly exhibited a diffuse localiza-
tion, although in some instances very faint staining resem-
bling focal adhesions could be observed. This observation
indicates that the pp60c-src SH2 binding site on FAK is
required for the effective relocalization of pp60c-src to cellu-
lar focal adhesions upon coexpression with FAK.
The NH2-terminal half of Src, containing the unique SH3
and SH2 domains, has been reported to localize to focal
adhesions (Kaplan et al., 1994). Similarly, SrcDPK was found
localized in the focal adhesions of many cells, although some
cells exhibited the perinuclear staining pattern seen with
full-length pp60c-src (Figure 12A). Coexpression of FAK with
SrcDPK led to very intense focal adhesion staining with the
anti-Src mAb EC10 in all cells expressing SrcDPK (Figure 12B).
Therefore, the FAK-dependent relocalization of pp60c-src
appears to be mediated through the NH2-terminal half of
pp60c-src.
DISCUSSION
The experiments described in this report were designed to
explore the interplay between FAK and pp60c-src in vivo to
elucidate how these two PTKs might regulate one another.
The results indicate that complex formation between FAK
and pp60c-src can induce the relocalization of pp60c-src from
a diffuse cellular distribution to a focal adhesion localization.
Furthermore, these two PTKs synergized in vivo to induce
the tyrosine phosphorylation of cellular proteins. Complex
formation may be a mechanism to regulate the conformation
of pp60c-src because its negative regulatory site, which is
usually phosphorylated and bound intramolecularly to the
SH2 domain, is dephosphorylated when bound to FAK.
Thus FAK may regulate pp60c-src via two distinct mecha-
nisms: 1) by controlling subcellular localization and hence
access to substrates and 2) by inducing a conformational
change that may lead to enzymatic activation or by binding
and stabilizing Src molecules that were activated via another
mechanism.
In these experiments, overexpression of pp60c-src induced
tyrosine phosphorylation of some cellular proteins. This was
unexpected because a number of other studies have re-
ported no increase of tyrosine phosphorylation upon over-
expression of pp60c-src; however, several recent reports
show that exogenous expression of c-Src in CE cells or
src2/2 fibroblasts induces tyrosine phosphorylation of pax-
illin (Richardson et al., 1997; Klinghoffer et al., 1999). These
results are presumably due to the level of expression, which
perhaps exceeds the regulatory capacity of endogenous Csk.
Despite this observation, coexpression with FAK with Src in
CE cells induced an elevation in tyrosine phosphorylation.
Figure 6. Coimmunoprecipitation of FAK variants with src and
fyn. Src immune complexes (A) or fyn immune complexes (B) were
probed for FAK by Western blotting. (A) Src immune complexes
from lysates of CE cells (lane 1) or CE cells expressing RCAS B src
(lane 2), RCAS A FAK 1 RCAS B src (lane 3), RCAS A FAK397F 1
RCAS B src (lane 4), RCAS A FAK576/577FF 1 RCAS B src (lane 5),
RCAS A FAK454R 1 RCAS B src (lane 6), or RCAS A FAK454R/397F 1
RCAS B src (lane 7) were analyzed. (B) Fyn immune complexes from
lysates of CE cells expressing RCAS B fyn (lane 1), RCAS A FAK 1
RCAS B fyn (lane 2), RCAS A FAK397F 1 RCAS B fyn (lane 3), RCAS
A FAK454R 1 RCAS B fyn (lane 4), or RCAS A FAK454R/397F 1 RCAS
B fyn (lane 5) were analyzed.
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In contrast, p59fyn was tightly regulated in this system be-
cause its overexpression did not induce tyrosine phosphor-
ylation of cellular proteins. Coexpression of FAK with p59fyn
induced tyrosine phosphorylation of cellular proteins. It is
therefore unlikely that these observations are due solely to
leaky repression of the Src PTKs in this system.
pp60v-src, and in some scenarios pp60c-src, has been found
localized in focal adhesions or related structures in src-
transformed cells (Rohrschneider, 1980; Howell and Cooper,
1994; Kaplan et al., 1994). We have demonstrated that coex-
pression of FAK with pp60c-src induces a dramatic relocal-
ization of the latter to focal adhesions. In contrast, coexpres-
sion of pp60c-src with FAK397F did not cause a dramatic
relocalization of pp60c-src, although these cells could some-
times exhibit very faint focal adhesion localization of pp60c-src.
Because this observation was not seen in cells expressing
pp60c-src alone, this small effect was also FAK dependent. Al-
though the major mechanism of interaction between FAK and
Src is SH2 domain-mediated, there is also a functional Src SH3
domain binding site in FAK (Thomas et al., 1998). It is possible
that the small amount of pp60c-src that may be found in focal
adhesions in FAK397F cells may be a result of SH3-mediated
interactions. The fact that FAK397F does not effectively alter the
localization of pp60c-src suggests that the autophosphoryla-
tion/Src SH2 domain binding site plays an important role in
the relocalization of pp60c-src. The most obvious explanation
for this result is that targeting of pp60c-src to focal adhesions in
this system is mediated by a direct interaction between FAK
and the SH2 domain of Src; however, mutational analysis of
Src has led to the proposal that targeting of Src to focal adhe-
sions is mediated by SH3 domain interactions (Kaplan et al.,
1994). Three focal adhesion-associated proteins are capable of
interacting with Src via its SH3 domain: paxillin (Weng et al.,
1993), p130cas (Nakamoto et al., 1996), and FAK (Thomas et al.,
1998). Perhaps there are multiple mechanisms, including
both SH2 and SH3 domain-mediated interactions, by which
pp60c-src may become localized to focal adhesions. Alter-
natively, the FAK-induced alteration in localization of pp60c-src
may be a consequence of promoting the interaction of pp60c-src
with a focal adhesion-localized SH3 binding site.
In addition to altering the localization of pp60c-src, coex-
pression with FAK enhances tyrosine phosphorylation of
focal adhesion-associated substrates. This could simply be a
consequence of targeting pp60c-src to the location of these
substrates. Alternatively, the formation of the FAK/pp60c-src
complex could result in enhancement of the catalytic activity
of either of these enzymes; however, the catalytic activity of
exogenous FAK is not required to cooperate with pp60c-src
and p59fyn to induce paxillin phosphorylation. It is therefore
unlikely that paxillin phosphorylation is the result of en-
hanced FAK activity induced by Src or fyn. In their re-
pressed state, Src family PTKs are tyrosine-phosphorylated
at their negatively regulatory C-terminal tyrosine residue,
and the regulatory domain forms an intramolecular interac-
tion with the SH2 domain. This in turn stabilizes an intramo-
lecular SH3 domain interaction that is important for altering
Figure 7. Tyrosine phosphorylation of paxillin in
cells coexpressing FAK variants and Src or fyn. Paxil-
lin was immunoprecipitated from cell lysates and
Western blotted for phosphotyrosine (top panels) and
for paxillin (bottom panels). (A) Paxillin was immu-
noprecipitated from lysates of CE cells (lane 1) or CE
cells expressing RCAS B fyn (lane 2), RCAS A FAK
(lane 3), RCAS A FAK 1 RCAS B fyn (lane 4), RCAS A
FAK576/577FF (lane 5), or RCAS A FAK576/577FF 1
RCAS B fyn (lane 6). (B) Paxillin was immunoprecipi-
tated from lysates of CE cells (lane 1) or CE cells
expressing RCAS B fyn (lane 2), RCAS A FAK (lane 3),
RCAS A FAK 1 RCAS B fyn (lane 4), RCAS A FAK397F
(lane 5), RCAS A FAK397F 1 RCAS B fyn (lane 6),
RCAS A FAK454R (lane 7), RCAS A FAK454R 1 RCAS
B fyn (lane 8), RCAS A FAK454R/397F (lane 9), or RCAS
A FAK454R/397F 1 RCAS B fyn (lane 10). (C) Paxillin
was immunoprecipitated from lysates of CE cells (lane
1) or CE cells expressing RCAS A FAK (lane 2), RCAS
B Src (lane 3), RCAS A FAK 1 RCAS B Src (lane 4),
RCAS A FAK397F 1 RCAS B Src (lane 5), RCAS A
FAK576/577FF 1 RCAS B fyn (lane 6), or RCAS A
FAK454R 1 RCAS B fyn (lane 7). (D–F) Twenty-five
micrograms of lysate were blotted for FAK, Src, or fyn.
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the catalytic domain to repress enzymatic activity. When
complexed with FAK, the C-terminal negative regulatory
domain of pp60c-src is hypophosphorylated. At the very least
this demonstrates an alteration in the conformation of the
protein, because the regulatory phosphorylated tyrosine res-
idue is no longer protected from dephosphorylation via its
interaction with the SH2 domain. This observation is consis-
tent with the hypothesis that pp60c-src is in its activated
conformation when complexed with FAK.
Three different mechanisms could lead to the presence of
activated pp60c-src/p59fyn in complex with FAK. First,
pp60c-src/p59fyn and FAK could become activated indepen-
dently, then activated pp60c-src/p59fyn could bind to ty-
rosine phosphorylated FAK. Second, pp60c-src/p59fyn could
become activated, phosphorylate FAK at tyrosine 397 to
create an SH2 binding site, and then bind to FAK. The
common feature of these models is that pp60c-src/p59fyn
activation occurs independently of FAK. PDGF stimulation
activates pp60c-src and reportedly stimulates tyrosine phos-
Figure 8. Focal adhesion targeting of FAK is required for induc-
tion of paxillin phosphorylation. (A) Paxillin was immunoprecipi-
tated from lysates of CE cells (lane 1) or CE cells expressing RCAS
A FAK (lane 2), RCAS A dl853–963 (lane 3), RCAS A dl965–1012
(lane 4), RCAS B Src (lane 5), RCAS A FAK 1 RCAS B Src (lane 6),
RCAS A dl853–963 1 RCAS B Src (lane 7), or RCAS A dl965–1012 1
RCAS B Src (lane 8). The immune complexes were blotted for
phosphotyrosine (top panel) or paxillin (second panel from top). A
25-mg aliquot of each lysate was Western-blotted for FAK (third
panel from top) and Src (bottom panel). (B) Paxillin was immuno-
precipitated from lysates of CE cells (lane 1) or CE cells expressing
RCAS A FAK (lane 2), RCAS A dl853–963 (lane 3), RCAS A dl965–
1012 (lane 4), RCAS B fyn (lane 5), RCAS A FAK 1 RCAS B fyn (lane
6), RCAS A dl853–963 1 RCAS B fyn (lane 7), or RCAS A dl965–1012
1 RCAS B fyn (lane 8). The immune complexes were blotted for
phosphotyrosine (top panel) or paxillin (second panel from top). A
25-mg aliquot of each lysate was Western-blotted for FAK (third
panel from top) and fyn (bottom panel).
Figure 9. Tyrosine 527 of pp60c-src is hypophosphorylated when in
complex with FAK. CE cells overexpressing pp60c-src and FAK were
labeled with 32P-orthophosphate and lysed. (A) Src was immuno-
precipitated from cells using mAb EC10 (right lanes), and FAK was
immunoprecipitated using mAb 2A7 (left lanes). The immune com-
plexes were resolved by SDS-PAGE and transferred to nitrocellu-
lose and labeled proteins were visualized by autoradiography. The
positions of molecular weight markers are indicated. (B) The 60-kDa
pp60c-src band was cut out from each sample and cleaved with
CNBr, and the fragments were resolved using a tricine polyacryl-
amide gel. Radiolabeled fragments were visualized by autoradiog-
raphy. Shown are the cleavage products of pp60src from the EC10
immune complex (lane 2) or from the 2A7 immune complex (lane 1).
The positions of molecular weight markers are indicated.
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phorylation of FAK, although it is not known whether as-
sembly of the pp60c-src/FAK complex occurs (Ralston and
Bishop, 1985; Gould and Hunter, 1988; Rankin and Rozen-
gurt, 1994; Abedi et al., 1995). Because pp60c-src interacts
directly with the PDGF receptor, it is likely that pp60c-src
activation in this situation is independent of FAK (Kypta et
al., 1990; Mori et al., 1993). Bombesin induces tyrosine phos-
phorylation of FAK and activation of pp60c-src in Swiss 3T3
cells (Zachary et al., 1992; Rodriguez-Fernandez and Rozen-
gurt, 1996). pp60c-src activation appears to be independent of
FAK because pp60c-src is activated under conditions in
which FAK is not tyrosine-phosphorylated (and presumably
does not bind pp60c-src) (Rodriguez-Fernandez and Rozen-
gurt, 1996). In each of these scenarios, formation of the
Figure 11. Autophosphorylation site if FAK is required for efficient relocalization of Src. CE cells expressing RCAS B c-src and RCAS A
FAK397F were fixed, permeabilized, and stained with BC4 to detect FAK localization (A and C) and with EC10 to detect Src localization (B
and D).
Figure 10 (facing page). FAK-dependent relocalization of pp60c-src to focal adhesions. CE cells (expressing no exogenous protein) were
fixed, permeabilized, and stained with monoclonal antibody EC10 to detect endogenous Src (A) or with BC4 to detect endogenous FAK (B).
Rhodamine-conjugated goat anti-mouse secondary antibodies were used to detect the primary mAb, and fluorescein-conjugated donkey
anti-rabbit secondary antibodies were used to detect BC4. Cells expressing pRL c-src (C) or pRL c-src 1 RCAS B FAK (D) were stained with
EC10 to detect Src. CE cells expressing RCAS B c-src 1 RCAS A FAK (E and F) were stained with BC4 to examine FAK localization (E) and
with EC10 to detect the localization of exogenously expressed c-src (F).
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complex could function to stabilize pp60c-src/p59fyn in its
active conformation. In the third mechanism, FAK may be-
come activated and autophosphorylate to create the Src SH2
binding site. The Src SH2 and SH3 binding sites within FAK
conform to high-affinity binding sites (Songyang et al., 1993;
Yu et al., 1994; Sparks et al., 1996; Thomas et al., 1998). These
sites may compete with the intramolecular Src SH2 and SH3
binding sites, which are low-affinity binding sites, resulting
in the disruption of the intramolecular interactions that re-
press catalytic activity. In this scenario, a direct consequence
of complex formation would be the enzymatic activation of
pp60c-src/p59fyn. A number of reports have demonstrated
that disruption of intramolecular SH2 and SH3 interactions
in pp60c-src causes enzymatic activation (Liu et al., 1993;
Alonso et al., 1995; Alexandropoulos and Baltimore, 1996;
Moarefi et al., 1997). In fact, pp60c-src can be activated in vitro
using peptides that mimic the SH2 and SH3 binding sites
within FAK (Thomas et al., 1998). Thus, multiple mecha-
nisms may control assembly of the FAK/Src complex, and
different mechanisms could be used in response to distinct
cellular stimuli.
There has been some discussion about the identity of the
PTK responsible for tyrosine phosphorylation of focal adhe-
sion-associated substrates. Both Src and FAK can phosphor-
ylate paxillin and p130cas in vitro (Bellis et al., 1995; Schaller
and Parsons, 1995; Vuori et al., 1996). These substrates are
also tyrosine-phosphorylated in src-transformed cells and
can become tyrosine-phosphorylated under certain condi-
tions after FAK overexpression (Glenney and Zokas, 1989;
Kanner et al., 1990; Sakai et al., 1994; Schaller and Parsons,
1995; Frisch et al., 1996; Vuori et al., 1996). Tyrosine phos-
phorylation of paxillin and p130cas can be induced by a
CD2/FAK chimeric molecule, and catalytic activity is re-
quired (Frisch et al., 1996; Vuori et al., 1996). In contrast,
catalytically defective FAK can cooperate with Src kinases to
induce paxillin phosphorylation in CE cells. Although FAK
or CD2 FAK can induce tyrosine phosphorylation of focal
adhesion proteins, mutants that fail to associate with Src
cannot (Schaller and Parsons, 1995; Frisch et al., 1996; Vuori
et al., 1996). Thus there is a consensus that the Src binding
site of FAK is absolutely required for inducing tyrosine
phosphorylation of substrates. Other studies have used cells
derived from knockout embryos to examine this question.
Cells from fak2/2 mice exhibit normal phosphorylation of
multiple focal adhesion-associated proteins, including pax-
illin, tensin, and p130cas (Ilic et al., 1995; Vuori et al., 1996). In
contrast, fibroblasts derived from src2/2 mice exhibit de-
fects in tyrosine phosphorylation of p130cas (Bockholt and
Burridge, 1995; Vuori et al., 1996; Schlaepfer et al., 1997).
Furthermore, cells derived from csk2/2 embryos exhibit
enhanced tyrosine phosphorylation of focal adhesion-asso-
ciated proteins. This effect is due to activation of endogenous
Src family PTKs because csk2/2/src2/2 and csk2/2/fyn2/2
double mutants exhibit levels of phosphotyrosine that are
closer to the levels in wild-type cells (Thomas et al., 1995).
The combined results of these studies suggest that the Src
kinases are responsible for directly phosphorylating focal
adhesion-associated proteins. FAK’s role in inducing ty-
rosine phosphorylation of focal adhesion substrates may be
in activating and recruiting Src family PTKs to their sub-
strates.
Our results describing the capacity of FAK mutants to
induce tyrosine phosphorylation in vivo complement results
from other laboratories describing the ability of various
mutants to elicit biological responses. FAK functions in con-
trolling the rate of cell spreading and cell migration (Cary et
al., 1996; Gilmore and Romer, 1996; Richardson and Parsons,
1996). The catalytic activity of FAK is dispensable for en-
hancing the rate of cell spreading and cell migration, but the
autophosphorylation site is essential (Cary et al., 1996; Rich-
ardson et al., 1997). It is possible that FAK functions in these
cases to recruit and/or activate Src-like PTKs to elicit ty-
rosine phosphorylation of downstream substrates, like pax-
illin, to mediate the downstream responses. FAK also func-
tions as part of an integrin-signaling pathway that prevents
adherent cells from undergoing apoptosis (Frisch et al., 1996;
Hungerford et al., 1996). Both the catalytic activity of FAK
and its autophosphorylation site are required to block apo-
ptosis when cells are detached from the extracellular matrix
(Frisch et al., 1996). It is intriguing that the requirements for
different biological responses are different. One trivial inter-
pretation is that in nonadherent cells, endogenous wild-type
FAK or Src-like PTKs may be unable to phosphorylate ex-
ogenous catalytically defective FAK to facilitate association
with Src family PTKs and transmission of a signal. Alterna-
tively, some FAK responses may be mediated via associated
Figure 12. srcDPK prominently localizes to focal adhesions when coexpressed with FAK. CE cells expressing srcDPK or srcDPK and FAK were
stained with mAb EC10 to examine the subcellular distribution of srcDPK.
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Src family PTKs that phosphorylate one set of substrates,
whereas other FAK responses require the phosphorylation
of a set of substrates by FAK itself.
The data presented in this manuscript support the con-
tention that the complex formed between FAK and the Src-
like PTKs is fundamentally important for both biochemical
and biological responses regulated by FAK. The results also
support the hypothesis that both the enzymatic activity of
the Src family kinases and their subcellular localization may
be regulated by association with FAK. Further experiments
to fully elucidate the mechanisms regulating the assembly
and disassembly of this complex are required to completely
understand the dynamics of FAK signaling.
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